Greater Cannabis Company Inc (GCAN)

[Releasemas]

Oraltabs.com means nothing to gcan current stock price. It has been stated that our relationship is only one of IP and or the GCAN patented technology of a fully dissolving patch. So far GCAN has been paid $2,600 for consulting. It does not matter what symtomax is selling. It only matters to us if they are paying gcan for the IP. Is it per patch produced? Per patch sold? Is it a percent of profit. Are we paid by flat fee? How is gcan monetizing its IP. GCAN stockholders should know this. It does no good to say we are selling our IP, but have no idea how we are getting paid for what we bringing to the table.